Acute Liver Failure

Slide 1 · Acute Liver Failure

Pathogenesis · Morphology · Clinicopathologic consequences

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning goals

Define acute liver failure by temporal course, encephalopathy, and coagulopathy.

Differentiate direct toxic injury, immune-mediated necrosis, and metabolic dysfunction.

Recognize the gross and microscopic patterns of hepatocyte loss.

Explain encephalopathy, synthetic failure, cholestasis, and renal complications.

Slide 3 · The defining syndrome

Acute liver illness

Coagulopathy

Encephalopathy

+

+

All components arise within 26 weeks of initial injury, without preexisting liver disease.

Slide 4 · Time window for acute liver failure

Initial injury

Beginning of liver insult

Usually ≤8 weeks

Most manifestations develop early

By 26 weeks

Outer definition window

Measure symptom onset → liver failure interval; Timing helps suggest the cause.

Slide 5 · Why the time course matters

Rapid progression particularly suggests a drug or toxin.

Acetaminophen-associated failure may follow symptoms within one week.

Virus-associated failure usually develops over a longer interval.

Timing is etiologic context—not proof of a specific cause.

Slide 6 · Liver reserve versus acute collapse

Preserved hepatic reserve

Mild injury may be clinically silent.

Remaining hepatocytes sustain metabolic and synthetic tasks.

Abnormal tests may precede symptoms.

Rapid loss of reserve

Diffuse acute injury overwhelms functional reserve.

Excretion, synthesis, and detoxification become impaired.

Neurologic and bleeding manifestations can follow.

Slide 7 · How different insults converge

Drug, virus, immune,

Vascular or metabolic insult

Hepatocyte death

Or severe dysfunction

Failure of hepatic

Homeostasis

Acute failure is a functional syndrome; Massive necrosis is common but not universal.

Slide 8 · Major etiologic classes

Class

Representative causes in Robbins

Toxic or drug-related

Acetaminophen; other drugs and toxins

Immune/infectious

Autoimmune hepatitis; hepatitis A, B or E

Other uncommon causes

Abnormal blood flow; metabolic disorders; malignancies

Unknown

No cause established despite evaluation

Slide 9 · Geographic differences in etiology

United States (adults)

Acetaminophen is a leading cause.

Autoimmune hepatitis and other drugs contribute.

Acute hepatitis A and B are important causes.

Asia

Acute hepatitis B and E predominate in the text.

Regional infectious epidemiology differs.

The textbook gives geographic context, not a universal hierarchy.

Slide 10 · Acetaminophen: Epidemiologic importance

Accidental or deliberate ingestion can cause acute liver failure.

Almost 50% of adult ALF cases in the United States to acetaminophen.

This figure is the textbook’s geographic estimate; It is not generalized globally.

Clinical history should therefore specifically consider exposure.

Slide 11 · Acetaminophen: Rapid deterioration

Exposure

Toxic insult

Hours to days

Hepatic injury evolves

Within a week

Failure may become evident

The course may be too rapid for appreciable scarring or regeneration.

Slide 12 · Direct toxin-mediated hepatocyte death

Toxic hepatic exposure

Direct hepatocellular injury

Massive necrosis

And functional loss

Acetaminophen is the exemplar of direct toxic injury in the source.

Slide 13 · Immune-associated hepatocyte injury

Viral hepatitis

Toxic and immune-mediated

Hepatocyte destruction

Extensive parenchymal loss

The immune response can amplify hepatocyte injury during infection.

Slide 14 · Toxic versus viral failure

Direct toxic pattern

Often abrupt clinical progression.

Extensive necrosis may occur in hours to days.

Little time for scar or regenerative response.

Viral hepatitis pattern

Often evolves over weeks to months.

Injury continues while repair attempts occur.

Regeneration and scarring can coexist.

Slide 15 · Autoimmune hepatitis and acute failure

Autoimmune hepatitis is among the important non-acetaminophen causes in adults.

Immune-mediated hepatocyte destruction can be severe enough to cause acute failure.

Histologic injury may overlap patterns of severe hepatitis from other etiologies.

Etiology cannot be assigned from necrosis alone.

Slide 16 · Other drug- and toxin-related causes

Not all toxic failure follows acetaminophen exposure.

Some drugs induce extensive cell death; Others profoundly impair metabolism.

Nature and duration of the injury influence the morphologic pattern.

A severe toxin-associated syndrome may occur without substantial fibrosis.

Slide 17 · Circulatory injury as an uncommon cause

Abnormal hepatic blood flow is a rare cause of acute liver failure.

Ischemic or hypoxic insults can produce marked hepatocyte necrosis.

Confluent injury may be accentuated near central veins.

Secondary vascular insults may enlarge areas of necrosis during hepatitis.

Slide 18 · Metabolic causes of acute liver failure

Metabolic disorders are among the uncommon etiologies.

Severe failure need not correspond to massive hepatocyte dropout.

Mitochondrial dysfunction can impair cellular energy metabolism.

Diffuse microvesicular steatosis is an important morphologic clue.

Slide 19 · Malignancy-associated acute liver failure

Malignancies are an uncommon cause of the acute failure syndrome.

The text particularly identifies leukemia and lymphoma.

Metastatic malignancies, including breast and colon cancer, also appear among reported causes.

Hepatic dysfunction may follow widespread infiltration rather than a typical toxin pattern.

Slide 20 · When the cause remains unknown

Adults

No established cause in approximately 15% of cases.

An indeterminate designation is descriptive.

Children

No established cause in approximately 50% of cases.

Do not infer a specific mechanism from the absence of a diagnosis.

Slide 21 · Interpreting an acute failure presentation

Clinical interval

Exposure and systemic

Disease context

Biochemical and

Morphologic pattern

Combine observations; Any single laboratory test or necrosis pattern is insufficient to establish etiology.

Slide 22 · Hepatocyte dysfunction and cell death

Potentially reversible changes

Steatosis or intracellular bilirubin retention.

Hepatocyte ballooning and cytoplasmic changes.

Cellular dysfunction before loss of viability.

Irreversible injury

Necrosis: Swelling, membrane damage and rupture.

Apoptosis: Shrinkage and acidophil bodies.

Confluent death can destroy wide lobular territories.

Slide 23 · Cellular events in hepatocyte necrosis

Membrane transport failure

And ionic imbalance

Cell swelling, Ca²⁺ accumulation

And mitochondrial dysfunction

Rupture, danger signals

And macrophage cleanup

Necrotic loss of hepatocytes reduces the mass available for hepatic function.

Slide 24 · Apoptosis as an additional hepatocyte response

Programmed cell death produces cell shrinkage and nuclear condensation.

Nuclear fragmentation and acidophilic apoptotic bodies may be present.

Acidophil bodies can occur in acute and chronic hepatitis.

Apoptosis is distinct from confluent necrosis, which removes contiguous groups of cells.

Slide 25 · Hepatic acinar zonation and injury

Portal

Tract

Zone 1

Zone 2

Zone 3

Central

Vein

Schematic acinar sequence: Zone 1 is periportal; Zone 3 is perivenular and relatively less oxygenated.

Slide 26 · Confluent necrosis: Contiguous cell loss

Conceptual parenchyma map

Muted red: Hepatocyte dropout

Green: Retained parenchyma

Contiguous hepatocyte loss can create a broad zone of necrosis.

Schematic only — not a histologic specimen or measured distribution.

Slide 27 · Bridging necrosis: Injury across landmarks

Conceptual parenchyma map

Muted red: Hepatocyte dropout

Green: Retained parenchyma

Confluent injury may connect vascular landmarks within a lobule.

Schematic only — not a histologic specimen or measured distribution.

Slide 28 · Pan-acinar necrosis: Whole-lobule loss

Conceptual parenchyma map

Muted red: Hepatocyte dropout

Green: Retained parenchyma

The whole lobule may be obliterated in pan-acinar necrosis.

Schematic only — not a histologic specimen or measured distribution.

Slide 29 · Massive hepatic necrosis in acute failure

Conceptual parenchyma map

Muted red: Hepatocyte dropout

Green: Retained parenchyma

ALF may leave only scattered islands of viable or regenerating hepatocytes.

Schematic only — not a histologic specimen or measured distribution.

Slide 30 · Acute failure: Enlargement may precede shrinkage

Early: Swelling, edema, infiltrates

Later: Shrunken, necrotic liver

Schematic outline comparison, not an anatomical illustration or size measurement.

Slide 31 · Gross appearance of massive necrosis

With severe destruction, the liver may become small and shrunken.

The textbook example is bile-stained, soft, and congested.

Broad zones of parenchymal loss may coexist with surviving islands.

A macroscopic pattern alone does not identify the initiating insult.

Slide 32 · Surviving hepatocytes after extensive injury

Conceptual parenchyma map

Muted red: Hepatocyte dropout

Green: Retained parenchyma

Preserved cell islands can coexist with extensive parenchymal destruction.

Schematic only — not a histologic specimen or measured distribution.

Slide 33 · Acetaminophen and perivenular necrosis

Portal

Tract

Zone 1

Zone 2

Zone 3

Central

Vein

Acetaminophen-associated confluent necrosis may be perivenular (zone 3).

Slide 34 · Histologic evolution: Tempo shapes repair

Hours to days

Toxic necrosis may progress too quickly for scar formation.

Little regenerative response may be visible early.

Weeks to months

Viral injury may persist while hepatocytes regenerate.

Ductular reactions and scarring can become apparent.

Slide 35 · Regeneration during severe parenchymal injury

Hepatocyte loss

Replication of remaining

Hepatocytes

Ductular reaction may

Accompany repair

The balance between ongoing loss and regeneration governs the resulting tissue pattern.

Slide 36 · Why scarring varies in acute failure

Rapid toxic insult

Minimal interval for scar deposition

Sustained injury

Persistent cell loss and repair

Longer course

Scarring may become visible

Fibrosis is not a required morphologic feature of acute liver failure.

Slide 37 · Acute failure with little visible necrosis

Usual pattern

Massive parenchymal necrosis.

Marked hepatocyte dropout.

Small and shrunken liver late in disease.

Unusual functional pattern

Widespread metabolic dysfunction.

Little overt hepatocyte death may be evident.

Diffuse microvesicular steatosis is a key example.

Slide 38 · Acute fatty liver of pregnancy

The source identifies acute fatty liver of pregnancy as a setting of diffuse microvesicular steatosis.

Severe failure may arise despite relatively limited overt hepatocyte death.

The functional disturbance is generally linked to mitochondrial dysfunction.

The hallmark distinction is metabolic incapacity versus massive necrosis.

Slide 39 · Idiosyncratic drug reactions and steatosis

Valproate and tetracycline as examples.

Diffuse microvesicular steatosis may accompany profound metabolic failure.

Mitochondrial dysfunction can prevent normal hepatocellular functions.

This path is different from a predominantly necrotic drug injury.

Slide 40 · Mitochondrial failure → functional collapse

Mitochondrial dysfunction

Disturbed hepatocyte

Metabolic activity

Loss of integrated

Organ functions

Extensive hepatocyte necrosis is not necessary for a severe functional syndrome.

Slide 41 · Non-hepatotropic viruses in immunodeficiency

Viruses named

Clinical setting noted

Cytomegalovirus

Advanced immunodeficiency and posttransplant suppression

Herpes simplex viruses

Immunodeficient patients

Adenovirus

Immunodeficient patients

Slide 42 · Typical clinical evolution

Early

Nausea and vomiting

Developing

Jaundice and hepatic injury

Severe

Coagulopathy and encephalopathy

Critical

Multiorgan failure may ensue

The sequence is illustrative; Not every patient follows identical timing.

Slide 43 · What serum aminotransferases represent

AST and ALT are cytosolic hepatocellular enzymes.

Marked elevations commonly accompany acute failure.

Enzyme release indicates hepatocellular injury—not directly the remaining liver reserve.

Interpret the trajectory alongside bilirubin, synthesis, and neurologic status.

Slide 44 · A falling transaminase level may mislead

Recovery is plausible when…

Clinical status stabilizes or improves.

Jaundice and coagulopathy do not progress.

Neurologic status does not deteriorate.

Extensive cell loss is plausible when…

Few viable cells remain to release enzymes.

Jaundice and coagulation failure worsen.

Encephalopathy progresses despite falling AST/ALT.

Slide 45 · Functional tests reveal hepatic failure

Cell injury

(AST/ALT)

Excretory function

(bilirubin)

Synthetic function

(coagulation factors)

No single analyte substitutes for the combined clinical syndrome.

Slide 46 · Cholestasis from hepatocellular dysfunction

Altered bile formation

And flow

Retention of bilirubin

And other biliary solutes

Jaundice / icterus

Cholestasis is a functional consequence of severe hepatic injury.

Slide 47 · Jaundice and icterus

Jaundice

Yellow discoloration of skin.

Linked to retained bilirubin.

Icterus

Yellow discoloration of conjunctivae.

Also reflects bilirubin retention.

Slide 48 · Infection risk in acute failure

Severe liver dysfunction is associated with increased bacterial infection risk.

The textbook particularly notes potentially life-threatening infection in this setting.

Infection can compound the physiologic burden of hepatic failure.

A worsening patient requires attention beyond hepatic biochemical results alone.

Slide 49 · Hepatic encephalopathy: Clinical spectrum

Early

Behavioral or cognitive disturbance

Progressing

Confusion and stupor

Advanced

Deep coma

Worst outcome

Death

Changes in consciousness are essential to the syndrome definition.

Slide 50 · Neurologic findings in encephalopathy

The patient may display fluctuating neurologic signs.

Rigidity and hyperreflexia are described in the source.

Asterixis is particularly characteristic, though not specific to a cause.

Encephalopathy may develop quickly or over a longer interval after hepatic injury.

Slide 51 · Asterixis: What the examiner observes

Arms extended;

Wrists dorsiflexed

Brief lapses of

Maintained posture

Nonrhythmic rapid

Flexion–extension

Asterixis is a bedside sign, not a histologic or biochemical test.

Slide 52 · Ammonia production and hepatic clearance

GI microorganisms

And enterocytes

Portal transport

To the liver

Urea-cycle detoxification

In hepatocytes

Acute liver failure disrupts the final detoxification step.

Slide 53 · Normal and failed ammonia handling

Working liver

Ammonia reaches hepatocytes through portal blood.

Urea-cycle activity detoxifies ammonia.

Systemic exposure is constrained.

Severe hepatic failure

Ammonia removal becomes insufficient.

Increased ammonia is associated with CNS dysfunction.

Cerebral edema can accompany the syndrome.

Slide 54 · A proposed pathway to cerebral edema

Elevated ammonia

Astrocyte metabolism

To glutamine

Intracellular osmotic

Effects and edema

This as a proposed mechanism, not the only cause of encephalopathy.

Slide 55 · Why encephalopathy can be fatal

Neurologic impairment can advance from subtle behavior change to coma.

Hyperammonemia correlates with impaired neuronal function and cerebral edema.

The source notes both direct neuronal and indirect astrocytic mechanisms as proposals.

Cerebral edema represents a severe neurologic complication.

Slide 56 · Hepatocellular synthesis and coagulation

Hepatic synthetic products

Consequences of profound failure

Factors II, V, VII, IX and X

Lower functional clotting-factor availability

Factors XI and XII; fibrinogen

Further loss of hemostatic proteins

Clearance of activated factors

Loss of regulation may contribute to DIC

Slide 57 · Coagulopathy and bleeding risk

Reduced clotting-factor

Synthesis

Bruising and

Hemorrhagic risk

Potentially severe

Intracranial bleeding

Impaired clearance of activated factors may also contribute to disseminated intravascular coagulation.

Slide 58 · Acute portal hypertension

Diminished portal

Venous flow

Predominantly intrahepatic

Obstruction in ALF

Portal pressure rise

Within days to weeks

Portal hypertension is more typical of chronic disease but can complicate acute failure.

Slide 59 · Ascites from acute portal hypertension

Intrahepatic flow

Impairment

Portal hypertension

Ascites

Ascites is the major consequence emphasized for acute portal hypertension.

Slide 60 · Proposed pathogenesis of hepatorenal syndrome

Splanchnic vasodilation

(including nitric oxide)

Reduced effective

Renal perfusion

Renin–angiotensin

Activation

Further reduction in

Renal filtration

This is a proposed hemodynamic sequence; Pathophysiology is not fully established.

Slide 61 · Renal presentation of hepatorenal syndrome

Urine output falls as kidney perfusion deteriorates.

Blood urea and creatinine concentrations rise.

The syndrome occurs without intrinsic kidney disease explaining the failure.

Fulminant hepatic failure may precipitate this complication, although cirrhosis is the more usual setting.

Slide 62 · Why renal dysfunction may reverse

The major mechanism presented is hemodynamic rather than destructive renal pathology.

Renin–angiotensin activation aggravates perfusion defects.

Renal function may improve when liver function is restored.

Liver transplantation is the example of recovery given in the text.

Slide 63 · Acute failure versus chronic failure

Characteristic

Acute liver failure

Chronic failure / cirrhosis

Time course

Within 26 weeks of initial injury

Progresses over months to years

Typical pathology

Massive necrosis or metabolic failure

Fibrous septa and regenerative nodules

Portal hypertension

Possible; often intrahepatic obstruction

Frequent; complex vascular consequences

Slide 64 · Why early recognition is consequential

Worsening hepatocyte

Functional reserve

Encephalopathy, bleeding,

Renal or circulatory failure

Multiorgan failure

And possible death

The source explicitly identifies transplantation as a possible life-saving intervention.

Slide 65 · Case application: Rapid-onset toxic pattern

A patient develops marked aminotransferase elevation, jaundice, and deteriorating consciousness within days of an acetaminophen exposure. Later, AST/ALT begin to decline as coagulopathy worsens.

Which interpretation of the falling enzymes is unsafe?

Assuming recovery: A declining release of enzymes may accompany loss of viable hepatocyte mass.

Slide 66 · Case application: Function without massive necrosis

A pregnant patient develops profound hepatic dysfunction. Tissue assessment reveals extensive microvesicular steatosis without the massive hepatocyte loss typical of many toxic failures.

Which pathophysiologic category fits best?

Predominant metabolic / mitochondrial hepatocyte dysfunction, as described for acute fatty liver of pregnancy.

Slide 67 · Case application: Neurologic progression

Following severe acute hepatitis, a patient develops altered behavior, asterixis, confusion, and subsequently impaired consciousness.

Which physiological defect helps explain the CNS syndrome?

Failed hepatic ammonia detoxification; Astrocyte glutamine accumulation is one proposed edema mechanism.

Slide 68 · The integrated pathology of acute liver failure

Primary lesion or dysfunction

Observable clinical consequence

Massive necrosis / mitochondrial failure

Rapid loss of hepatic function

Impaired bile formation and flow

Hyperbilirubinemia; jaundice and icterus

Reduced synthesis; altered coagulation clearance

Coagulopathy and hemorrhagic risk

Failed ammonia clearance

Encephalopathy and cerebral edema

Portal and systemic hemodynamic disturbance

Ascites; possible hepatorenal syndrome

Slide 69 · Synthesis: Essential distinctions

Acute liver failure is a clinical syndrome, not a single histologic lesion.

Direct toxicity and immune-mediated injury often cause extensive hepatocyte necrosis.

Mitochondrial dysfunction can produce severe failure without extensive cell death.

The liver’s loss of synthesis, excretion and detoxification explains the life-threatening phenotype.

Slide 70 · Primary teaching source

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th edition (2026).

Chapter 18: Liver and Gallbladder — Acute Liver Failure (printed pp. 751–753).

Supporting context: Hepatocyte and Parenchymal Responses; Scar Formation and Regression (printed pp. 749–751).

The original textbook figures were not reproduced; all diagrams in this lecture are editable schematics.